PSME3 and cancer: Notably, higher levels of PSME3 exhibited a robust positive correlation with neutrophils, B cells, CD4 T cells, CD8 T cells, and M2 macrophages in cancers such as HNSC, KIRC, KICH, PRAD, and UVM.